Abstract
The relative ability of the calcium chelates of calcium disodium ethylenediaminetetraacetate (EDTA) and calcium trisodium ethylenetriaminepentaacetate (DTPA) to protect mice against lethal doses of Clostridium perfringens α-toxin was investigated. Their protective ability was assayed by the increase in survival time of mice which had been given large doses of toxin, and by determining the median protective dose of chelate that would protect mice against toxin at a minimum lethal dose of two. In both assay procedures, intraperitoneal, intravenous, and intracutaneous injections of toxin were utilized, and with each toxin injection route the protective ability of the chelate was determined with the three routes of injection. DTPA was 10 to 20 times more effective than EDTA with both types of assay procedure and with all injection routes. DTPA may be superior to EDTA as a protective agent not only because it binds zinc to a greater extent, but also because of its greater retention in the body and its ability to gain entrance into cells. It appears that DTPA may be of value as a therapeutic agent in gas-gangrene.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ELLNER P. D. Fate of partially purified C-14-labeled toxin of Clostridium perfringens. J Bacteriol. 1961 Aug;82:275–283. doi: 10.1128/jb.82.2.275-283.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grossman I. W., Heitkamp D. H., Sacktor B. Morphologic and biochemical effects of Clostridium perfringens alpha toxin on intact and isolated skeletal muscle mitochondria. Am J Pathol. 1967 Jan;50(1):77–88. [PMC free article] [PubMed] [Google Scholar]
- Lynch K. L., Moskowitz M. Relationship of route of inoculation and nature of toxin preparation to bioassay of Clostridium perfringens alpha-toxin in mice. J Bacteriol. 1968 Dec;96(6):1920–1924. doi: 10.1128/jb.96.6.1920-1924.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MOSKOWITZ M., DEVERELL M. W., MCKINNEY R. Protection against Clostridium perfringens type A toxin by a metal-chelating compound. Science. 1956 Jun 15;123(3207):1077–1078. doi: 10.1126/science.123.3207.1077. [DOI] [PubMed] [Google Scholar]
- MOSKOWITZ M. Metal chelates as therapeutic and detoxifying agents in gas gangrene. Proc Soc Exp Biol Med. 1956 Aug-Sep;92(4):706–709. doi: 10.3181/00379727-92-22587. [DOI] [PubMed] [Google Scholar]
- MOSKOWITZ M. Mode of action of chelates in protecting against Clostridium perfringens toxin. Nature. 1958 Feb 22;181(4608):550–551. doi: 10.1038/181550a0. [DOI] [PubMed] [Google Scholar]
- PULLMAN T. N., LAVENDER A. R., FORLAND M. Synthetic chelating agents in clinical medicine. Annu Rev Med. 1963;14:175–194. doi: 10.1146/annurev.me.14.020163.001135. [DOI] [PubMed] [Google Scholar]
- TREFFERS H. P. The linear representation of dosage-response curves in microbial-antibiotic assays. J Bacteriol. 1956 Jul;72(1):108–114. doi: 10.1128/jb.72.1.108-114.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WEINER M. The influence of the physiologic disposition of chelates on their use in medicine. Ann N Y Acad Sci. 1960 Aug 18;88:426–434. doi: 10.1111/j.1749-6632.1960.tb20040.x. [DOI] [PubMed] [Google Scholar]